Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleCorrection to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.AuthorsArmstrong, Andrew J.; Geva, Ravit; Chung, Hyun Cheol; Lemech, Charlotte; Miller Jr, Wilson H.; Hansen, Aaron R.; Lee, Jong-Seok; Tsai, Frank; Solomon, Benjamin J.; Kim, Tae Min; Rolfo, Christian; Giranda, Vincent; Ren, Yixin; Liu, Fang; Kandala, Bhargava; Freshwater, Tomoko; Wang, Judy S.PublicationInvestigational New Drugs, 2024, Vol 42, Issue 3, p340ISSN0167-6997Publication typeCorrection NoticeDOI10.1007/s10637-024-01444-0